Opportunity Information: Apply for RFA NR 12 004
Apply for RFA NR 12 004
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Palliative Care and End of Life in People Living with HIV/AIDS(R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.361 Nursing Research.
- This funding opportunity was created on Dec 2, 2011 and posted on Dec 2, 2011.
- Applicants must submit their applications by Mar 22, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $2,100,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $300,000.00 in funding.
- Eligible applicants include: State governments Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Public housing authorities/Indian housing authorities Special district governments Small businesses Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments City or township governments Public and State controlled institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Independent school districts.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are noteligible to apply. Non domestic (non U.S.) components of U.S. Organizations are noteligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity, titled "Palliative Care and End of Life in People Living with HIV/AIDS (R01)" (Funding Opportunity Number RFA-NR-12-004), was issued by the National Institutes of Health through the National Institute of Nursing Research (NINR). It supports R01 research projects that focus on the real-world palliative care (PC) and end-of-life (EOL) needs of people living with HIV/AIDS (PLWHA). The core idea behind the announcement is that highly active antiretroviral therapy (HAART) has significantly extended life expectancy, which means more individuals are now living long enough to experience later-stage illness, complex symptom burdens, and chronic comorbidities. As a result, the need for high-quality palliative care and thoughtful end-of-life support has grown, especially in communities where HIV prevalence remains high and HIV-related mortality is still most severe. The opportunity is positioned in the education and health domain under CFDA 93.361 (Nursing Research), emphasizing that nursing and interdisciplinary care models are central to improving quality of life, symptom management, decision-making, and support for patients and families over the course of serious illness.
The grant mechanism is a discretionary research grant (R01), with an estimated total program funding level of about $2.1 million and an anticipated award ceiling of $300,000. There is no cost sharing or matching requirement, which lowers the barrier for applicants who might otherwise struggle to secure non-federal matching funds. The announcement was posted on December 2, 2011, and it used a single application due date of March 22, 2012, with the opportunity archived on April 22, 2012. In practical terms, this was a time-limited solicitation meant to stimulate focused research activity in an area where clinical needs were changing rapidly as HIV became a more chronic, life-prolonged condition for many patients.
Eligibility was broad and designed to include a wide range of organizations that could contribute to HIV palliative and end-of-life research. Eligible applicants included state, county, city or township governments; federally recognized tribal governments and other tribal organizations; public and state-controlled institutions of higher education as well as private institutions of higher education; nonprofit organizations both with and without 501(c)(3) status; small businesses and other for-profit entities (with small businesses explicitly listed); special district governments; public housing authorities and Indian housing authorities; and independent school districts. The announcement also clarifies that additional eligible applicants included faith-based and community-based organizations, Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian Serving Institutions, tribally controlled colleges and universities (TCCUs), regional organizations, eligible federal agencies, and U.S. territories or possessions. At the same time, it clearly excludes non-U.S. entities: foreign institutions were not eligible to apply, non-domestic components of U.S. organizations were not eligible, and foreign components (as NIH defines them in its Grants Policy Statement) were not allowed. This structure signals that the research was intended to be conducted and managed within the U.S. context, likely reflecting both policy constraints and a desire to strengthen domestic systems of HIV palliative and end-of-life care.
From a research standpoint, the opportunity encourages work that directly addresses the evolving clinical and supportive care realities for PLWHA, particularly those approaching the later stages of disease or facing life-limiting complications. While the short description does not list specific research topics, the emphasis on "current" PC and EOL needs implies a strong interest in identifying gaps in care, testing interventions, improving delivery models, and generating evidence that can be implemented in real clinical settings. The explicit focus on populations with the highest prevalence and mortality highlights health equity concerns and points toward research that is attentive to disparities, access barriers, and culturally responsive care. Overall, the announcement frames palliative care and end-of-life support not as an add-on, but as an essential part of comprehensive HIV care in the HAART era, aiming to improve quality of life, relieve suffering, and better support patients, caregivers, and communities most affected by HIV/AIDS.
For applicants or readers seeking the full details at the time, NIH provided an official link to the announcement (http://grants.nih.gov/grants/guide/rfa-files/RFA-NR-12-004.html) and directed technical access questions to the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
Frequently Asked Questions (FAQs)
1) What is the title and funding opportunity number for this grant?
The opportunity is titled "Palliative Care and End of Life in People Living with HIV/AIDS (R01)" and the Funding Opportunity Number is RFA-NR-12-004.
2) Which agency and institute issued this funding opportunity?
This funding opportunity was issued by the National Institutes of Health (NIH) through the National Institute of Nursing Research (NINR).
3) What type of grant mechanism is being used?
The mechanism is an NIH discretionary research grant using the R01 research project format.
4) What is the overall purpose of this R01 opportunity?
It supports R01 research projects focused on real-world palliative care (PC) and end-of-life (EOL) needs of people living with HIV/AIDS (PLWHA), reflecting changing needs as HIV has become a longer-term condition for many people in the HAART era.
5) Why does this opportunity emphasize palliative care and end-of-life needs for people living with HIV/AIDS?
The announcement highlights that highly active antiretroviral therapy (HAART) has extended life expectancy. As a result, more individuals live long enough to experience later-stage illness, complex symptom burdens, and chronic comorbidities, increasing the need for high-quality palliative care and end-of-life support.
6) What kinds of research does the announcement appear to encourage?
Based on the emphasis provided, the opportunity encourages research that addresses current PC and EOL needs for PLWHA, including identifying gaps in care, testing interventions, improving care delivery models, and producing evidence that can be implemented in real clinical settings.
7) Does this opportunity have a health equity or disparities emphasis?
Yes. The description notes particular concern for communities where HIV prevalence remains high and HIV-related mortality is most severe, suggesting interest in research attentive to disparities, access barriers, and culturally responsive care.
8) What program area or CFDA listing is associated with this opportunity?
The opportunity is positioned in the education and health domain under CFDA 93.361 (Nursing Research).
9) How does nursing fit into the intent of this funding announcement?
The description emphasizes that nursing and interdisciplinary care models are central to improving quality of life, symptom management, decision-making, and support for patients and families over the course of serious illness.
10) How much total funding was expected for the program?
The estimated total program funding level is about $2.1 million.
11) Is there an award ceiling, and if so, what is it?
Yes. The anticipated award ceiling is $300,000.
12) Is cost sharing or matching required?
No. The opportunity states there is no cost sharing or matching requirement.
13) When was this opportunity posted, and what were the key dates?
The announcement was posted on December 2, 2011. It used a single application due date of March 22, 2012. The opportunity was archived on April 22, 2012.
14) Was this a rolling deadline opportunity?
No. The information provided indicates it used a single application due date (March 22, 2012), which means it was time-limited rather than accepting applications on a rolling basis.
15) Is this opportunity still open?
No. It was archived on April 22, 2012, and the single due date listed was March 22, 2012.
16) What types of organizations were eligible to apply?
Eligibility was broad and included many U.S.-based organization types, including government entities (state, county, city/township), federally recognized tribal governments and other tribal organizations, public and private institutions of higher education, nonprofits (with or without 501(c)(3) status), for-profit entities including small businesses, special district governments, public housing authorities/Indian housing authorities, and independent school districts.
17) Are community-based and faith-based organizations eligible?
Yes. The announcement explicitly notes that faith-based and community-based organizations were included among additional eligible applicants.
18) Are minority-serving institutions specifically recognized as eligible?
Yes. The announcement specifically identifies Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian Serving Institutions, and tribally controlled colleges and universities (TCCUs) as eligible.
19) Are U.S. territories or possessions eligible to apply?
Yes. The opportunity notes that U.S. territories or possessions were included among eligible applicants.
20) Are federal agencies eligible applicants?
Yes. The opportunity lists eligible federal agencies among additional eligible applicants.
21) Are foreign institutions allowed to apply?
No. The announcement explicitly excludes non-U.S. entities: foreign institutions were not eligible to apply.
22) Can a U.S. organization submit an application with a non-domestic component?
No. The announcement states that non-domestic components of U.S. organizations were not eligible.
23) Are foreign components (as defined by NIH) allowed under this opportunity?
No. The announcement states that foreign components (as NIH defines them in its Grants Policy Statement) were not allowed.
24) Where could applicants find the official full announcement?
NIH provided the official link to the announcement at: http://grants.nih.gov/grants/guide/rfa-files/RFA-NR-12-004.html
25) Who was listed as the contact for technical access questions?
Technical access questions were directed to the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
26) What does "real-world" palliative care and end-of-life needs imply in this context?
Based on the text provided, it implies an emphasis on practical, implementable evidence and care approaches that work in real clinical settings for PLWHA, particularly as they experience complex symptoms, chronic comorbidities, and later-stage illness.
27) What patient groups are at the center of this opportunity?
The focus is on people living with HIV/AIDS (PLWHA), especially those approaching later stages of disease or facing life-limiting complications, and those in communities with the highest HIV prevalence and the most severe HIV-related mortality.
28) What outcomes or goals are highlighted by the announcement?
The opportunity frames palliative care and end-of-life support as essential to comprehensive HIV care in the HAART era, aiming to improve quality of life, relieve suffering, and better support patients, caregivers, and communities most affected by HIV/AIDS.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Palliative Care and End of Life in People Living with HIV/AIDS (R21)
Previous opportunity: Metabolomics Data Repository and Coordinating Center (DRCC) (U01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA NR 12 004
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA NR 12 004) also looked into and applied for these:
| Funding Opportunity |
|---|
| Palliative Care and End of Life in People Living with HIV/AIDS (R21) Apply for RFA NR 12 005 Funding Number: RFA NR 12 005 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Limited Competition Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54) Apply for PAR 12 055 Funding Number: PAR 12 055 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Limited Competition The Medical Education Partnership Initiative Linked Awards (MEPI) (R25) Apply for RFA TW 11 004 Funding Number: RFA TW 11 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| The Chernobyl Tissue Bank Coordinating Center (Limited Competition U24) Apply for RFA CA 12 501 Funding Number: RFA CA 12 501 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| NCI Mentored Research Scientist Development Award to Promote Diversity (K01) Apply for PAR 12 050 Funding Number: PAR 12 050 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08) Apply for PAR 12 051 Funding Number: PAR 12 051 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NCI Mentored Patient Oriented Research Career Development Award to Promote Diversity (K23) Apply for PAR 12 052 Funding Number: PAR 12 052 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Maternal Nutrition and Pre pregnancy Obesity Effects on Mothers, Infants and Children (R01) Apply for PA 12 061 Funding Number: PA 12 061 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| The NCI Transition Career Development Award to Promote Diversity (K22) Apply for PAR 12 062 Funding Number: PAR 12 062 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Early Stage Innovative Technology Development for Cancer Research (R21) Apply for RFA CA 12 002 Funding Number: RFA CA 12 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Validation and Advanced Development of Emerging Technologies for Cancer Research (R33) Apply for RFA CA 12 003 Funding Number: RFA CA 12 003 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Innovative and Early Stage Development of Emerging Technologies in Biospecimen Science (R21) Apply for RFA CA 12 004 Funding Number: RFA CA 12 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Validation and Advanced Development of Emerging Technologies in Biospecimen Science (R33) Apply for RFA CA 12 005 Funding Number: RFA CA 12 005 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| NCI Established Investigator Award in Cancer Prevention and Control (K05) Apply for PAR 12 065 Funding Number: PAR 12 065 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Imaging Science Track Award for Research Transition (I/START) R03 Apply for PAR 12 066 Funding Number: PAR 12 066 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Human Health and Heredity in Africa (H3Africa) Research Grants (U01) Apply for RFA RM 12 004 Funding Number: RFA RM 12 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Small Grants for Behavioral Research in Cancer Control (R03) Apply for PAR 12 035 Funding Number: PAR 12 035 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award (K07) Apply for PAR 12 067 Funding Number: PAR 12 067 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Fogarty HIV Research Training Program for Low and Middle Income Country Institutions (D43) Apply for PAR 12 068 Funding Number: PAR 12 068 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Pediatric Phase 1/Pilot Consortium (Limited Competition UM1) Apply for RFA CA 12 502 Funding Number: RFA CA 12 502 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA NR 12 004", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.